newsArtificial intelligence technology will drive manufacture of high-quality biosimilars at…
16 May 2023 | By Catherine Eckford (European Pharmaceutical Review)
Artificial intelligence technology will drive manufacture of high-quality biosimilars at scale under a partnership between Sandoz and Just - Evotec Biologics.